• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

formulary

China flag against blue sky
Pharma

China unveils 19 meds picked for new private insurance formulary

China's National Healthcare Security Administration selected 19 meds for its Commercial Health Insurance Innovative Drug Catalogue.
Zoey Becker Dec 8, 2025 4:45pm
Wegovy

Novo's Wegovy secures preferred obesity spot on CVS formulary

May 1, 2025 2:39pm
Indivior cut its sales forecast after Suboxone marketing indictment

Indivior signs $600M deal to settle opioid marketing accusations

Jul 27, 2020 12:23pm
Roche

UnitedHealthcare backs Amgen biosims over Roche's oncology meds

Aug 16, 2019 10:55am
fighting

Novo’s oral semaglutide could disrupt diabetes coverage: analyst

Mar 5, 2019 12:05pm
Aimovig

CVS sidelines Amgen's Aimovig in favor of Teva, Lilly CGRP drugs

Jan 28, 2019 11:45am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings